title: "Adaptive pathways" to drug authorisation: adapting to industry?
authors.affiliation: Department of Social Science, Health and Medicine, King's College London, London, UK courtney.davis@kcl.ac.uk.
authors.forename: Courtney
authors.initials: C
authors.lastname: Davis
authors.affiliation: School of Health Policy and Management, York University, Toronto, Ontario, Canada.
authors.forename: Joel
authors.initials: J
authors.lastname: Lexchin
authors.affiliation: Centre for Evidence Based Medicine, Oxford, UK.
authors.forename: Tom
authors.initials: T
authors.lastname: Jefferson
authors.affiliation: Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark.
authors.forename: Peter
authors.initials: P
authors.lastname: Gøtzsche
authors.affiliation: London School of Hygiene and Tropical Medicine, London, UK.
authors.forename: Martin
authors.initials: M
authors.lastname: McKee
mesh_terms: D017277:Drug Approval / Q000379:methods; D004345:Drug Industry; D004358:Drug Therapy; D004335:Drug and Narcotic Control; D064420:Drug-Related Side Effects and Adverse Reactions; D005060:Europe; D006801:Humans; D018570:Risk Assessment; D013997:Time Factors